The Promise and Obstacle of p53 as a Cancer Therapeutic Agent

By  

Current Molecular Medicine, Vol. 2, Iss. 4, 2002-06 ,pp. : 329-345

Bentham Science Publishers

Access to resources Recommend Favorite

Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention

By Park W.-C.   Jordan V.C.  

Trends in Molecular Medicine, Vol. 8, Iss. 2, 2002-02 ,pp. : 82-88

Elsevier

Access to resources Recommend Favorite

Characterization of Human Papillomavirus Infection, P53 and Ki-67 Expression in Cervix Cancer of Mozambican Women

By Carrilho Carla   Gouveia Patricia   Cantel Martha   Alberto Matos   Buane Landim   David Leonor  

Pathology Research and Practice, Vol. 199, Iss. 5, 2003-07 ,pp. : 303-311

Urban & Fischer

Access to resources Recommend Favorite

Fluorescence in Situ Hybridization Analysis of HER-2/neu, c-myc, and p53 in Endometrial Cancer

By Williams J.A.   Wang Z.-R.   Parrish R.S.   Hazlett L.J.   Smith S.T.   Young S.R.  

Experimental and Molecular Pathology, Vol. 67, Iss. 3, 1999-12 ,pp. : 135-143

Elsevier

Access to resources Recommend Favorite

Effect of p53 gene transfection on vascular endothelial growth factor expression in endometrial cancer cells

By Fujisawa T.   Watanabe J.   Kamata Y.   Hamano M.   Hata H.   Kuramoto H.  

Experimental and Molecular Pathology, Vol. 74, Iss. 3, 2003-06 ,pp. : 276-281

Elsevier

Access to resources Recommend Favorite